Drug General Information
Drug ID
D03YXI
Former ID
DIB012233
Drug Name
PIKAMILONE
Synonyms
N-Nicotinoyl-gamma-aminobutyric acid sodium salt; N-(3-Pyridylcarbonyl)-4-aminobutyric acid sodium salt
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Phase 2 [522726]
Structure
Download
2D MOL

3D MOL

Formula
C10H12N2O3
Canonical SMILES
C1=CC(=CN=C1)C(=O)NCCCC(=O)O
InChI
1S/C10H12N2O3/c13-9(14)4-2-6-12-10(15)8-3-1-5-11-7-8/h1,3,5,7H,2,4,6H2,(H,12,15)(H,13,14)
InChIKey
NAJVRARAUNYNDX-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor Target Info Modulator [551871]
References
Ref 522726ClinicalTrials.gov (NCT00940186) Clinical Pharmacokinetics Study on Pikamilone. U.S. National Institutes of Health.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.